|
EXOC6B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.033600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.482750E-01 |
| Normal-vs-Stage2 |
1.510380E-01 |
| Normal-vs-Stage3 |
1.878610E-01 |
| Normal-vs-Stage4 |
3.088000E-01 |
| Stage1-vs-Stage2 |
6.970400E-01 |
| Stage1-vs-Stage3 |
9.375800E-01 |
| Stage1-vs-Stage4 |
8.639400E-01 |
| Stage2-vs-Stage3 |
7.348600E-01 |
| Stage2-vs-Stage4 |
8.629200E-01 |
| Stage3-vs-Stage4 |
9.123200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.009600E-01 |
| Normal-vs-AfricanAmerican |
5.339400E-01 |
| Normal-vs-Asian |
9.854000E-02 |
| Caucasian-vs-AfricanAmerican |
1.698380E-01 |
| Caucasian-vs-Asian |
4.248000E-01 |
| AfricanAmerican-vs-Asian |
1.494040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.518500E-03 |
| Normal-vs-Female |
3.187000E-01 |
| Male-vs-Female |
1.510450E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.255800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.203800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.769700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.310040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.603900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.408620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.104200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.314200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.216600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.732600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.385600E-01 |
| Classical-VS-Follicular |
1.371200E-04 |
| Classical-VS-Other |
3.020700E-03 |
| Classical-VS-Normal |
5.792400E-01 |
| Tall-VS-Follicular |
3.254400E-02 |
| Tall-VS-Other |
6.739600E-03 |
| Tall-VS-Normal |
9.264400E-01 |
| Follicular-VS-Other |
3.525800E-01 |
| Follicular-VS-Normal |
4.019400E-04 |
| Other-VS-Normal |
3.558100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.109590E-02 |
| Normal-vs-N1 |
6.552600E-01 |
| N0-vs-N1 |
3.663400E-01 |
|
|
